awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38116768-11D6C3B7-C4E1-41E9-8C64-CB4A49F85C22
Q38116768-11D6C3B7-C4E1-41E9-8C64-CB4A49F85C22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38116768-11D6C3B7-C4E1-41E9-8C64-CB4A49F85C22
STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.
P2860
Q38116768-11D6C3B7-C4E1-41E9-8C64-CB4A49F85C22
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38116768-11D6C3B7-C4E1-41E9-8C64-CB4A49F85C22
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ef6140031b1a97f30d69b11f401d5cd3ace73e6
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.